Skip to content
Loading…
Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.